Sequent Scientific Share Price

₹ 219.00

-₹1.31 (-0.59%)
1D
Last updated 03 Nov, 2026, 15:29 IST
NSE: VIYASH
|
Pharmaceuticals

Sequent Scientific Share Price Today

As of 3 Nov 2026, Sequent Scientific share price is ₹219.00. The stock opened at ₹222.48, compared to its previous close of ₹220.31. During today's trading session, Sequent Scientific share price moved in the range of ₹218.20 to ₹222.99, with an average price of ₹220.59 for the day. Looking at its last 52-week, the stock has touched a low of ₹178.13 and a high of ₹298.00. On the performance front, Sequent Scientific share price has increased by 8.13% over the last six months and is up 2.66% on a year-on-year basis.

Share price over the last 1 day fell from 222.25 to 219.00, ranging between 218.81 and 222.47.
₹218.20
0.59% down today
₹222.99
1D LOW
1D HIGH

Sequent Scientific Stock Insights

Latest Earning
Op Profit TrendUp by 2548.10% YoY
Latest Earning
Net Profit TrendUp by 19.45% QoQ
Latest Earning
Revenue TrendUp by 2.01% QoQ
Stock Performance
OutperformingBeat Nifty by 11.07 % in last 6 month
Shareholding Pattern
PromoterPromoter decreased stake by 19.68%
Shareholding Pattern
DIIDII increased stake by 41.53%
Shareholding Pattern
FIIFII decreased stake by 42.26%
Sequent Scientific stock performance
Open₹222.48
High₹222.99
Low₹218.20
Prev. close₹220.31
Sequent Scientific trading activity
Volume8,47,696
Average traded price₹220.01
Last traded time03:29:58 03 Nov
Last traded quantity50
Circuit
L
H
₹176.25
₹264.37
52-week
L
H
₹178.13
₹298.00
Mkt Cap Cr
9,736.47
P/E
36.43
P/B
3.45
ROA
5.77%
ROE
7.07%
ROCE
13.01%
Quick Ratio
1.53
EV/EBITDA
13.82

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Viyash Scientific has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Viyash Scientific appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Viyash Scientific revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Sequent Scientific Company Background

ISIN
INE807F01027
Sector Market Cap
₹ 9,736.47 Cr

Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.

Sequent Scientific Financial Highlights

  • Revenue: Sequent Scientific reported revenue of ₹3,463.86 crore in FY26 vs ₹3,039.73 crore in FY25. It showed an increase of 13.95% on a yearly basis.
  • Operating Profit: Sequent Scientific reported an operating profit of ₹349.02 crore in FY26 vs ₹13.18 crore in FY25. It showed an increase of 2,548.10% on a year-on-year basis.
  • Net Profit: Sequent Scientific reported a net profit of ₹224.65 crore in FY26 vs ₹15.77 crore in FY25. It showed an increase of 1,324.54% on a yearly basis.

Sequent Scientific Quarterly Result Highlights

  • Sequent Scientific reported revenue of ₹954.67 crore in Jun 2026, compared with ₹935.88 crore in Mar 2026, representing an increase of 2.01% on a quarter-on-quarter (QoQ) basis.
  • Sequent Scientific reported an operating profit of ₹112.41 crore in Jun 2026, compared with ₹125.24 crore in Mar 2026, representing a decrease of 10.24% on a quarter-on-quarter (QoQ) basis.
  • Sequent Scientific reported a profit of ₹79.29 crore in Jun 2026, compared with ₹66.38 crore in Mar 2026, reflecting an increase of 19.45% on a QoQ basis.
  • The earnings per share (EPS) of Sequent Scientific stood at ₹4.09 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
49.24%
FII
2.60%
Other DII
1.17%
Retail and other
39.86%
Mutual funds
7.13%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20253.16%
Mar 20262.94%
Jun 20264.50%
Sep 20262.60%

Sequent Scientific Investment Returns

1 day
+0.88%
1 week
+5.98%
1 month
-4.94%
1 year
+2.66%
3 years
+125.50%
5 years
+25.46%

Sequent Scientific Share Price History

Sequent Scientific share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹218.39 / ₹220.31
+0.88%
30 Oct 26
₹224.59 / ₹218.39
-2.74%
29 Oct 26
₹228.90 / ₹224.55
-1.08%
28 Oct 26
₹215.00 / ₹227.00
+5.65%
Show more

Sequent Scientific Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,420.31₹3,006.84₹1,369.73₹1,420.91
Other Income₹43.55₹32.89₹10.96₹6.39
Total Revenue₹3,463.86₹3,039.73₹1,380.69₹1,427.30
Total Expenses₹3,070.63₹2,944.99₹1,417.94₹1,500.16
Profit Before Tax₹349.03₹13.18-₹54.65-₹137.66
Tax₹124.37-₹2.59-₹25.03-₹15.68
Profit After Tax₹224.65₹15.77-₹29.61-₹121.98
EPS - Basic₹4.09₹0.54-₹1.44-₹4.88
EPS - Diluted₹4.01₹0.53-₹1.44-₹4.88

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹349.03₹13.18-₹54.65-₹137.66
Income before WC changes₹713.41₹467.81₹90.32₹83.06
Change in Assets-₹388.10-₹183.62-₹8.54-₹34.60
Change in Liabilities₹58.94₹109.48-₹37.14-₹17.01
Change in WC-₹329.16-₹74.15-₹45.67-₹51.61
Cash flow from Operations₹322.91₹344.80₹30.60₹16.81
Cash flow from Investing-₹84.12-₹447.22-₹5.92-₹64.96
Cash flow from Financing-₹123.33₹87.04-₹1.44₹32.23
Total Cash Flow₹115.46-₹15.38₹23.24-₹15.92
Cash (Start of the year)₹140.30₹156.18₹41.57₹57.50
Cash (End of the year)₹255.76₹140.30₹64.81₹41.57

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,373.84₹2,349.48₹729.45₹749.33
Current Assets₹2,254.55₹1,782.79₹810.94₹779.79
Total Assets₹4,628.39₹4,132.27₹1,540.38₹1,529.12
Current Liabilities₹945.90₹1,015.11₹626.99₹558.76
Net Current Asset₹1,308.65₹767.67₹183.95₹221.04
Non-Current Liabilities₹567.76₹552.22₹200.44₹221.18
Equity Capital₹3,114.73₹2,564.94₹712.96₹749.19
Total Equity & Liabilities₹4,628.39₹4,132.27₹1,540.38₹1,529.12

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,382.06₹1,310.34₹168.52₹222.69
Other Income₹66.26₹72.21₹45.98₹28.24
Total Revenue₹1,448.32₹1,382.55₹214.50₹250.93
Total Expenses₹1,287.89₹1,251.92₹208.48₹260.67
Profit Before Tax₹116.22₹49.17-₹0.24-₹9.75
Tax₹40.35-₹9.32-₹0.86-₹3.67
Profit After Tax₹75.87₹58.49₹0.62-₹6.08
EPS - Basic₹1.75₹1.36₹0.03-₹0.24
EPS - Diluted₹1.72₹1.34₹0.03-₹0.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹116.22₹49.17-₹0.24-₹9.75
Income before WC changes₹262.77₹269.97-₹18.43-₹10.23
Change in Assets-₹93.64-₹121.74-₹11.45₹71.40
Change in Liabilities-₹38.71₹57.46₹0.67-₹22.72
Change in WC-₹132.35-₹64.28-₹10.77₹48.68
Cash flow from Operations₹119.12₹187.95-₹26.94₹37.75
Cash flow from Investing-₹106.88-₹410.18₹5.47-₹50.70
Cash flow from Financing-₹7.06₹195.38₹22.32₹0.24
Total Cash Flow₹5.18-₹26.85₹0.84-₹12.71
Cash (Start of the year)₹15.79₹43.15₹0.08₹12.80
Cash (End of the year)₹20.97₹15.79₹0.93₹0.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,692.59₹2,680.41₹1,090.82₹1,047.75
Current Assets₹962.45₹839.33₹96.78₹75.02
Total Assets₹3,655.04₹3,519.73₹1,187.60₹1,122.77
Current Liabilities₹415.77₹509.10₹98.16₹61.61
Net Current Asset₹546.68₹330.22-₹1.38₹13.42
Non-Current Liabilities₹50.20₹102.22₹2.21₹2.80
Equity Capital₹3,189.07₹2,908.41₹1,087.23₹1,058.36
Total Equity & Liabilities₹3,655.04₹3,519.73₹1,187.60₹1,122.77
* All values are in INR Crore
Sequent Scientific market depth
Bid quantityBid priceAsk priceAsk quantity
00219.451347
0000
0000
0000
0000
Total bid quantity0
Total ask quantity1,347
Sequent Scientific technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
43.16
Neutral
ATR (14)
10.08
Neutral
STOCH(9,6)
64.65
Neutral
STOCH RSI (14)
83.18
Bearish
ADX(9)
24.15
Bearish
UO(9)
51.33
Neutral
ROC(12)
-5.44
Bearish
WillR(14)
-42.12
Neutral
Period
Simple value
Exponential vaue
5D
221.02
219.64
10D
215.99
219.96
20D
224.43
224.72
50D
243.26
237.15
100D
254.68
242.36
Volume trend — traded volume by day
3 Nov8L
2 Nov8L
30 Oct11L
29 Oct25L
28 Oct45L
27 Oct14L
Average19L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Sequent Scientific
Pharmaceuticals
Add Stock
Add Another

Sequent Scientific Latest News

2 months ago
Block deals, August 26: Welspun Corp tumbles 6% after ₹1,433 crore trade; PhysicsWallah, 2 others see big deals
Showing news item 1 of 1

Sequent Scientific Share Price FAQs

Please be aware that Sequent Scientific stock prices are subject to continuous fluctuations due to various factors.